Full name
POLIFARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,2 | 1,9 | 1 | -45,8 |
EBITDA | 2,7 | 2,9 | 2 | -33,6 |
Short time liabilities | 23 | 21,5 | 26,6 | 23,4 |
Equity capital | 4,4 | 5,9 | 6,7 | 13,8 |
Operating profit (EBIT) | 2,4 | 2,6 | 1,6 | -38,5 |
Assets | 28 | 28,3 | 34,1 | 20,7 |
Net profit (loss) | 2,1 | 1,5 | 0,8 | -45,9 |
Cash | 0,3 | 0,5 | 0,6 | 14,5 |
Net income from sale | 72 | 83,1 | 90,5 | 8,9 |
Liabilities and provisions for liabilities | 23,6 | 22,4 | 27,4 | 22,5 |
Working assets | 12,1 | 12,5 | 17,3 | 38,2 |
Depreciation | 0,3 | 0,4 | 0,4 | 2,6 |
% | % | % | p.p. | |
Profitability of capital | 48,5 | 25,5 | 12,1 | -13,4 |
Equity capital to total assets | 15,7 | 20,9 | 19,7 | -1,2 |
Gross profit margin | 3 | 2,2 | 1,1 | -1,1 |
EBITDA Margin | 3,8 | 3,5 | 2,2 | -1,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 116 | 95 | 107 | 12 |
Current financial liquidity indicator | 0.5236498117446899 | 0.5750071406364441 | 0.6437671184539795 | 0 |
Net dept to EBITDA | 3.0486648082733154 | 2.3049299716949463 | 4.8100080490112305 | 2,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane